{"product_id":"american-academy-of-child-and-adolescent-psychiatry-pediatric-psychopharmacology-update-institute-2023","title":"American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2023","description":"\u003ch3 class=\"product_title entry-title\"\u003eAmerican Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2023\u003c\/h3\u003e\n\u003cstrong\u003e Include: 15 videos + 15 audios, size: 4.56 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: child and adolescent psychiatrists, general psychiatrists, pediatricians, psychologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"512\" data-start=\"0\"\u003eThe American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2023 is an intensive program designed to provide the most current, evidence-based information on the safe and effective use of psychotropic medications in children and adolescents. Led by leading experts in pediatric psychiatry and pharmacology, this course combines research updates with practical clinical guidance to support informed prescribing and optimal patient outcomes.\u003c\/p\u003e\n\u003cp data-end=\"539\" data-start=\"514\"\u003e\u003cstrong data-end=\"537\" data-start=\"514\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"970\" data-start=\"540\"\u003e\n\u003cli data-end=\"615\" data-start=\"540\"\u003e\n\u003cp data-end=\"615\" data-start=\"542\"\u003eLatest research and clinical guidelines in pediatric psychopharmacology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"736\" data-start=\"616\"\u003e\n\u003cp data-end=\"736\" data-start=\"618\"\u003eEvidence-based approaches to prescribing for mood disorders, anxiety, ADHD, psychosis, and other conditions in youth\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"816\" data-start=\"737\"\u003e\n\u003cp data-end=\"816\" data-start=\"739\"\u003eStrategies for monitoring efficacy, safety, and side effects of medications\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"904\" data-start=\"817\"\u003e\n\u003cp data-end=\"904\" data-start=\"819\"\u003eConsiderations for polypharmacy, special populations, and treatment-resistant cases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"970\" data-start=\"905\"\u003e\n\u003cp data-end=\"970\" data-start=\"907\"\u003eUpdates on emerging treatments and novel pharmacologic agents\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"991\" data-start=\"972\"\u003e\u003cstrong data-end=\"989\" data-start=\"972\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1443\" data-start=\"992\"\u003e\n\u003cli data-end=\"1109\" data-start=\"992\"\u003e\n\u003cp data-end=\"1109\" data-start=\"994\"\u003e\u003cstrong data-end=\"1004\" data-start=\"994\"\u003eEvent:\u003c\/strong\u003e American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2023\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1189\" data-start=\"1110\"\u003e\n\u003cp data-end=\"1189\" data-start=\"1112\"\u003e\u003cstrong data-end=\"1123\" data-start=\"1112\"\u003eFormat:\u003c\/strong\u003e Live virtual sessions with interactive Q\u0026amp;A and on-demand access\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1298\" data-start=\"1190\"\u003e\n\u003cp data-end=\"1298\" data-start=\"1192\"\u003e\u003cstrong data-end=\"1215\" data-start=\"1192\"\u003eProgram Highlights:\u003c\/strong\u003e Expert-led lectures, real-world case discussions, and practical prescribing tips\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1443\" data-start=\"1299\"\u003e\n\u003cp data-end=\"1443\" data-start=\"1301\"\u003e\u003cstrong data-end=\"1320\" data-start=\"1301\"\u003eTopics Covered:\u003c\/strong\u003e Psychopharmacology for ADHD, mood disorders, anxiety disorders, autism spectrum disorders, psychotic disorders, and more\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1697\" data-start=\"1445\"\u003e\u003cstrong data-end=\"1466\" data-start=\"1445\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eChild and adolescent psychiatrists, general psychiatrists, pediatricians, psychiatric nurse practitioners, psychologists, and other mental health professionals involved in the medication management of children and adolescents.\u003c\/p\u003e\n\u003cp data-end=\"2052\" data-is-last-node=\"\" data-is-only-node=\"\" data-start=\"1699\"\u003e\u003cstrong data-end=\"1713\" data-start=\"1699\"\u003eWhy Attend\u003c\/strong\u003e\u003cbr\u003eThis course offers a focused, high-value update on pediatric psychopharmacology, equipping clinicians with the knowledge and tools to prescribe safely and effectively. Attendees will leave with enhanced clinical confidence, up-to-date prescribing practices, and improved strategies for optimizing treatment outcomes in young patients.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAddressing Impulsivity and Aggression in Adolescents With Substance Use Disorders.mp3\u003cbr\u003eAddressing Impulsivity and Aggression in Adolescents With Substance Use Disorders.mp4\u003cbr\u003eAdvanced Psychopharmacology for Pediatric Anxiety Disorders.mp3\u003cbr\u003eAdvanced Psychopharmacology for Pediatric Anxiety Disorders.mp4\u003cbr\u003eAggression as a Transdiagnostic Symptom_ Oppositional Defiant Disorder, Intermittent Explosive Disorder, and Aggression ….mp3\u003cbr\u003eAggression as a Transdiagnostic Symptom_ Oppositional Defiant Disorder, Intermittent Explosive Disorder, and Aggression ….mp4\u003cbr\u003eAn Update on Management of Impulsive Aggression in Children With Attention-Deficit_Hyperactivity Disorder.mp3\u003cbr\u003eAn Update on Management of Impulsive Aggression in Children With Attention-Deficit_Hyperactivity Disorder.mp4\u003cbr\u003eClinical Approach to the Treatment of Pediatric Depression.mp3\u003cbr\u003eClinical Approach to the Treatment of Pediatric Depression.mp4\u003cbr\u003eOpening Remarks by the Past President of AACAP_ The Trouble With Outbursts.mp3\u003cbr\u003eOpening Remarks by the Past President of AACAP_ The Trouble With Outbursts.mp4\u003cbr\u003ePharmacogenetics of Second-Generation Antipsychotics and Mood Stabilizer Medications.mp3\u003cbr\u003ePharmacogenetics of Second-Generation Antipsychotics and Mood Stabilizer Medications.mp4\u003cbr\u003ePsychopharmacologic Approaches in Autism.mp3\u003cbr\u003ePsychopharmacologic Approaches in Autism.mp4\u003cbr\u003eQ\u0026amp;A Panel Discussion (1).mp3\u003cbr\u003eQ\u0026amp;A Panel Discussion (1).mp4\u003cbr\u003eQ\u0026amp;A Panel Discussion (2).mp3\u003cbr\u003eQ\u0026amp;A Panel Discussion (2).mp4\u003cbr\u003eQ\u0026amp;A Panel Discussion.mp3\u003cbr\u003eQ\u0026amp;A Panel Discussion.mp4\u003cbr\u003eTicked Off!! Explosive Outbursts in Tics_Tourette’s Disorder.mp3\u003cbr\u003eTicked Off!! Explosive Outbursts in Tics_Tourette’s Disorder.mp4\u003cbr\u003eTreating Aggression in Early Onset Schizophrenia and Bipolar Disorder.mp3\u003cbr\u003eTreating Aggression in Early Onset Schizophrenia and Bipolar Disorder.mp4\u003cbr\u003eWelcome – Day 1.mp3\u003cbr\u003eWelcome – Day 1.mp4\u003cbr\u003eWelcome – Day 2.mp3\u003cbr\u003eWelcome – Day 2.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954488283234,"sku":"MED-AMB04375","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/American-Academy-of-Child-and-Adolescent-Psychiatry-Pediatric-Psychopharmacology-Update-Institute-2023-scaled-1.jpg?v=1779377789","url":"https:\/\/meducourse.com\/products\/american-academy-of-child-and-adolescent-psychiatry-pediatric-psychopharmacology-update-institute-2023","provider":"Meducourse","version":"1.0","type":"link"}